Preventing fractures in the elderly in GP practice

References

• Van Schoor NM, Smit JH, et al. Prevention of hip fractures by external hip protectors. JAMA 2003; 289(15): 1957–62.
   PubMed Web of Science ®Google Scholar
• Torgerson DJ, Iglesias CP, Reid DM, Barlow DH, eds. The effective management of osteoporosis. London: Aesculaius Medical Press; 2001; The economics of fracture prevention. p. 111–21.
   Google Scholar
• Gabriel SE, Tosteson AN, Leibson CL. Direct medical costs attributable to osteoporosis fractures. Osteoporos Int 2002; 13: 323–30.
   PubMed Web of Science ®Google Scholar
• Saley DG, Browner WS, et al. Which fractures are associated with low appendicular bone mass in elderly women? Annals Int Med 1991; 115: 837–42.
   PubMed Web of Science ®Google Scholar
• Cooper C, Campion G, et al. Hip fractures in the elderly. Osteoporos Int 1992; 2: 285–9.
   PubMed Web of Science ®Google Scholar
• National Osteoporosis Foundation of South Africa. Osteoporosis Clinical Guideline. SAMJ 2000; 90(9): 905–44.
   Web of Science ®Google Scholar
• Wainwright SA, Marshall LM, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 2005; 90: 2787–93.
   PubMed Web of Science ®Google Scholar
• National Institute of Health Consensus Development Panel. Osteoporosis prevention, diagnosis and therapy. NIH Consensus Statement 2000; 17(1): 1–36.
   Google Scholar
• American Geriatric Society, British Geriatric Society, American Academy of Orthopaedic Surgeons Panel of Falls Prevention. J Am Geriatr Soc 2001; 49: 664–72.
   PubMedGoogle Scholar
• Rao SS. Prevention of falls in older patients. Am Fam Physician 2005; 72(1): 81–8.
   PubMed Web of Science ®Google Scholar
• Tinetti ME. Preventing falls in older persons. N Engl J Med 2003; 348: 42–9.
   PubMed Web of Science ®Google Scholar
• Shea B, Wells G, et al. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002; 23(4): 552–9.
   Google Scholar
• Papadimitropoulos E, Wells G, et al. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002; 23(4): 560–9.
   PubMed Web of Science ®Google Scholar
• Rosen CJ. Postmenopausal osteoporosis. N Engl J Med 2005; 353(4): 595–603.
   PubMed Web of Science ®Google Scholar
• Rapuri PB, Gallagher JC, et al. Alcohol intake and bone metabolism in elderly women. Am J Clin Nutr 2000; 72: 1206–13.
   PubMed Web of Science ®Google Scholar
• Cranney A, Wells G, et al. Meta-analysis of therapies for osteoporosis. II. Meta-analysis of Alendronate for the treatment of postmenopausal osteoporosis. Endocr Rev 2002; 23(4): 508–16.
   PubMed Web of Science ®Google Scholar
• Cummings SR Black DM, et al. Effect of Alendronate on risk of fracture in women with low bone density but without vertebral fractures. JAMA 1998; 280: 2077–82.
   PubMed Web of Science ®Google Scholar
• Ringe JD, Faber H, et al. Alendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study. J Clin Endocrinol Metab 2001; 86: 5252–5.
   PubMed Web of Science ®Google Scholar
• Orwoll E, Ettinger M, et al. Alendronate for the treatment of osteoporosis in men. N Engl J Med 2000; 343: 604–10.
   PubMed Web of Science ®Google Scholar
• Saag K, Emkey R, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998; 339: 292–9.
   PubMed Web of Science ®Google Scholar
• Bone HG, Hosking D, et al. Ten years experience with Alendronate for osteoporosis in postmenopausal women. N Engl J Med 2004; 350: 1189–99.
   PubMed Web of Science ®Google Scholar
• Cranney A, Tugwell P, et al. Meta-analysis of therapies for osteoporosis. IV. Meta-analysis of Raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev 2002; 23(4): 524–8.
   PubMed Web of Science ®Google Scholar
• Cummings SR, Eckert SE, Krueger KA. The effect of raloxifene on risk of breast cancer in postmenopausal women. JAMA 1999; 281(23): 2189–97.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E, Grady D, Sashegyi A, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: Four-year results from the MORE randomised trial. JAMA 2002; 287(7): 847–57.
   PubMed Web of Science ®Google Scholar
• Kannus P, Sievanen H, et al. Prevention of falls and consequent injuries in the elderly. Lancet 2005; 366: 1885–93.
   PubMed Web of Science ®Google Scholar
• Harwood RH, Foss AJ, et al. Falls and health status in elderly women following first eye cataract surgery: a randomised controlled trial. Br J Ophthalmology 2005; 89: 53–9.
   PubMed Web of Science ®Google Scholar
• Gillespie LD, Gillespie WJ, et al. Intervention for preventing falls in elderly people. Cochrane Database Syst Rev 2003; (4): CD 000340.
   Google Scholar
• Neer RM, Arnaud CD, Zanchetta JR et al. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001; 344: 1434–1441.
   PubMed Web of Science ®Google Scholar
• Kurland ES, Cosman F, McMahon D et al. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 2000; 85: 3069–3076
   PubMed Web of Science ®Google Scholar
• Lane NE, Sanchez S, Modin GW et al. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis: results of a randomised controlled clinical trial. J Clin Invest 1998; 102: 1627–1633
   PubMed Web of Science ®Google Scholar
• Meunier PJ, Roux C et al. The effects of Strontium Ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. NEJM Vol 350; January 2004; 459–468
   PubMed Web of Science ®Google Scholar
• Reginster JY, Seeman E et al. Strontium Ranelate reduces the risk of non-vertebral fractures in postmenopausal women with osteoporosis; treatment of peripheral osteoporosis (TROPOS) study. Journal of Clinical Endocrinology and Metabolism 90 (5); 2816–2822
   PubMed Web of Science ®Google Scholar